Min Wen

986 total citations
43 papers, 785 citations indexed

About

Min Wen is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Min Wen has authored 43 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Biotechnology. Recurrent topics in Min Wen's work include Cancer Research and Treatments (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Virus-based gene therapy research (3 papers). Min Wen is often cited by papers focused on Cancer Research and Treatments (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Virus-based gene therapy research (3 papers). Min Wen collaborates with scholars based in China, South Korea and United States. Min Wen's co-authors include Shin Jung, Charles E. Alpers, Stephan Segerer, Kelly L. Hudkins, Jian Pei, Kyung‐Sub Moon, Shu‐Guang Jin, In‐Young Kim, Tae‐Young Jung and Young‐Il Jeong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Min Wen

41 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Wen China 15 287 100 90 90 88 43 785
Xu Zhao China 18 526 1.8× 93 0.9× 105 1.2× 167 1.9× 43 0.5× 40 1.1k
Wenjing Liu China 22 677 2.4× 125 1.3× 70 0.8× 132 1.5× 65 0.7× 78 1.3k
Xiaochen Li China 18 511 1.8× 86 0.9× 40 0.4× 97 1.1× 85 1.0× 49 970
Linhe Lu China 16 347 1.2× 60 0.6× 99 1.1× 76 0.8× 23 0.3× 28 833
Mo Wang China 18 278 1.0× 82 0.8× 56 0.6× 51 0.6× 41 0.5× 67 816
Teng Wu China 18 377 1.3× 177 1.8× 96 1.1× 95 1.1× 23 0.3× 61 919
Ling Jiang China 18 353 1.2× 161 1.6× 71 0.8× 146 1.6× 23 0.3× 90 1.1k
Han Wu China 15 188 0.7× 60 0.6× 80 0.9× 43 0.5× 37 0.4× 44 718

Countries citing papers authored by Min Wen

Since Specialization
Citations

This map shows the geographic impact of Min Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Wen more than expected).

Fields of papers citing papers by Min Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Wen. The network helps show where Min Wen may publish in the future.

Co-authorship network of co-authors of Min Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Min Wen. A scholar is included among the top collaborators of Min Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Wen. Min Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Min, et al.. (2025). Experimental Study on R290 Performance of an Integrated Thermal Management System for Electric Vehicle. Energies. 18(4). 802–802. 1 indexed citations
2.
Wen, Min, Ran Tao, Jianchun Jiang, Yicun Chen, & Yandong Wang. (2025). Characterization and anti-Vibrio activity of citral-chitosan Schiff base complexed tannic acid-zinc slow-release bacteriostatic formulations. LWT. 224. 117780–117780. 2 indexed citations
3.
Zhang, Huaizhen, Zhiping Fan, Zhuang Ding, et al.. (2024). Encapsulation of astaxanthin in OSA-starch based amorphous solid dispersions with HPMCAS-HF/Soluplus® as effective recrystallization inhibitor. International Journal of Biological Macromolecules. 279(Pt 1). 135421–135421. 4 indexed citations
4.
5.
Liáng, Lìyı̌n, Renbin Liu, Xuting Zhang, et al.. (2024). Polydatin attenuates diabetic renal inflammatory fibrosis via the inhibition of STING pathway. Biochemical Pharmacology. 226. 116373–116373. 6 indexed citations
7.
Liáng, Lìyı̌n, Rui Chen, Min Wen, et al.. (2023). Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis. European Journal of Pharmacology. 955. 175915–175915. 8 indexed citations
8.
Guo, Yanxia, Xiaoqing Liu, Jinling Liu, et al.. (2023). Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapy. Theranostics. 13(15). 5546–5560. 11 indexed citations
9.
Wang, Kankai, Junnan Ru, Xiao Lin, et al.. (2020). Melatonin Enhances the Therapeutic Effect of Plasma Exosomes Against Cerebral Ischemia-Induced Pyroptosis Through the TLR4/NF-κB Pathway. Frontiers in Neuroscience. 14. 848–848. 78 indexed citations
10.
Xia, Lei, Su Yang, Chengde Wang, et al.. (2020). Immunohistochemical Profiles of Matrix Metalloproteinases and Vascular Endothelial Growth Factor Overexpression in the Antoni B Area of Vestibular Schwannomas. World Neurosurgery. 144. e72–e79. 13 indexed citations
11.
Li, Qun, Jianglong Lu, Jia Xia, Min Wen, & Chengde Wang. (2019). Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochemical and Biophysical Research Communications. 512(3). 558–563. 17 indexed citations
12.
Lu, Jianglong, Qun Li, Lin Cai, et al.. (2018). RBM17 controls apoptosis and proliferation to promote Glioma progression. Biochemical and Biophysical Research Communications. 505(1). 20–28. 12 indexed citations
13.
Sun, Jinqiao, Min Wen, Ying Wang, et al.. (2017). The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD. BMC Medical Genetics. 18(1). 127–127. 2 indexed citations
14.
Lu, Jianwei, et al.. (2016). Analysis of dynamic mechanism and global response of vehicle shimmy system with multi-clearance joints. Journal of Vibration and Control. 24(11). 2312–2326. 14 indexed citations
15.
Pei, Jian, Hyang‐Hwa Ryu, Songyuan Li, et al.. (2015). Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model. Radiation Oncology. 10(1). 164–164. 32 indexed citations
16.
Wen, Min, Jun Wu, Hui Luo, & Haitao Zhang. (2012). Galangin Induces Autophagy through Upregulation of p53 in HepG2 Cells. Pharmacology. 89(5-6). 247–255. 47 indexed citations
17.
Jeong, Young‐Il, Shu‐Guang Jin, In‐Young Kim, et al.. (2010). Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids and Surfaces B Biointerfaces. 79(1). 149–155. 75 indexed citations
18.
Wen, Min, Stephan Segerer, Márcio Dantas, et al.. (2002). Renal Injury in Apolipoprotein E–Deficient Mice. Laboratory Investigation. 82(8). 999–1006. 101 indexed citations
19.
Taneda, Sekiko, Stephan Segerer, Kelly L. Hudkins, et al.. (2001). Cryoglobulinemic Glomerulonephritis in Thymic Stromal Lymphopoietin Transgenic Mice. American Journal Of Pathology. 159(6). 2355–2369. 69 indexed citations
20.
Wen, Min. (1989). Mesangial proliferative change and mesangiolysis. Habu-snake venom induced glomerular lesions of the kidney.. Journal of Nippon Medical School. 56(1). 39–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026